Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – Here’s What Happened

Hypermarcas (OTCMKTS:HYPMY) gapped up prior to trading on Wednesday . The stock had previously closed at $4.65, but opened at $4.80. Hypermarcas shares last traded at $4.80, with a volume of 1,100 shares changing hands.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group raised Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Hypermarcas Stock Down 0.4%

The company has a current ratio of 1.86, a quick ratio of 1.26 and a debt-to-equity ratio of 0.50. The firm has a 50 day simple moving average of $4.25 and a two-hundred day simple moving average of $4.30. The company has a market capitalization of $3.35 billion, a PE ratio of 9.52 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 12.68%. Research analysts expect that Hypermarcas will post 0.53 EPS for the current year.

About Hypermarcas

Hypermarcas SA was a Brazilian consumer health and pharmaceutical company that developed, manufactured and marketed branded products for healthcare, personal care and consumer markets. Its portfolio historically included over-the-counter medicines, prescription products, vitamins, toiletries, cosmetics and other household or personal-care brands.

The company expanded through acquisitions and operated primarily in Brazil, building a broad portfolio of locally recognized brands. In the mid-2010s, Hypermarcas began divesting its non-pharmaceutical businesses to concentrate on healthcare and medicines.